lorazepam has been researched along with tamoxifen in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abdelkafi, H; Ait Ouarab, L; Barbier, J; Buisson, DA; Caramelle, L; Cintrat, JC; Clerget, A; Gillet, D; Michau, A; Montoir, D; Ngadjeua, F; Pons, V | 1 |
| Kruszewski, SP; Paczynski, R | 1 |
2 review(s) available for lorazepam and tamoxifen
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for lorazepam and tamoxifen
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Structure-Activity Relationship Studies of Retro-1 Analogues against Shiga Toxin.
Topics: Benzodiazepinones; Golgi Apparatus; HeLa Cells; Humans; Protein Transport; Shiga Toxins; Structure-Activity Relationship | 2020 |
Concomitant use of Lorazepam with tamoxifen in bipolar mania clinical trials.
Topics: Anticonvulsants; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Humans; Lorazepam; Protein Kinase C; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen | 2009 |